(a)

1. (1) The following pharmaceutical agents are authorized to be possessed, administered, and prescribed by a board-certified optometrist.

2. (2) The following agents are to be applied topically to the eye:

   1. (A) Anesthetics;
   2. (B) Anti-allergy;
   3. (C) Antibacterial/antiseptic;
   4. (D) Antibiotic;
   5. (E) Antifungal;
   6. (F) Antiglaucoma;
   7. (G) Antihistamine/decongestant;
   8. (H) Artificial tear preparation;
   9. (I) Anti-inflammatory;
   10. (J) Anti-inflammatory/antibiotic;
   11. (K) Anti-inflammatory/antibacterial;
   12. (L) Decongestants;
   13. (M) Decongestants/astringent;
   14. (N) Demulcents;
   15. (O) Dyes;
   16. (P) Emollients;
   17. (Q) Hyperosmotic agents;
   18. (R) Irrigation solution;
   19. (S) Lubricants;
   20. (T) Mydriatics;
   21. (U) Miotics;
   22. (V) Mydriatic/cycloplegics; and
   23. (W) Vasoconstrictors.
3. (3) The strength and manner in which these agents may be possessed, administered, and prescribed shall be in accordance with the reasonable standard of care accepted in the community in which the certified optometrist practices.

(b)

1. (1) Prior to beginning the treatment of patients for glaucoma, a certified optometrist shall consult with an ophthalmologist and develop a written protocol.

2. (2) Written protocol shall include the following:

   1. (A) Visual acuity;
   2. (B) Intraocular pressure; and
   3. (C) Evaluation of the:

(i) Optic nerve;

1. (ii) Visual fields; and

   1. (iii) Anterior chamber angle.

2. (3) The manner of care rendered by the optometrist:

   1. (A) Depends upon the individual written protocol established between the optometrist and the ophthalmologist; and

   2. (B) May be altered by mutual written consent on an as-needed basis.

      1. (c) The certified optometrist may remove superficial foreign bodies from the:
3. (1) Lid;
4. (2) Conjunctiva;
5. (3) Adnexa; and

6. (4) Cornea (not deeper than the posterior region of the Bowman’s membrane of the cornea).

   1. (d) This will certify that the foregoing rules governing the use of topical therapeutic drugs for optometric care by State Board of Optometry-certified optometrists were duly adopted by the board on May 1, 1997.